| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angina Pectoris: The Evolution of Concepts
|
Opie, Lionel H.
|
|
2004
|
|
1_suppl |
p. S3-S9
|
artikel
|
| 2 |
Antiarrhythmic and Proarrhythmic Properties of QT-Prolonging Antianginal Drugs
|
Singh, Bramah N.
|
|
2004
|
|
1_suppl |
p. S85-S97
|
artikel
|
| 3 |
Antiarrhythmic Drug Therapy of Atrial Fibrillation: Focus on New Agents
|
Dorian, Paul
|
|
2003
|
|
1_suppl |
p. S27-S31
|
artikel
|
| 4 |
Atrial Electrophysiology and Mechanisms of Atrial Fibrillation
|
Nattel, Stanley
|
|
2003
|
|
1_suppl |
p. S5-S11
|
artikel
|
| 5 |
Atrial Fibrillation: Emerging Possibilities for Drug Treatment: An Overview of Current Opportunities and Recent Developments
|
Papp, Julius Gy.
|
|
2003
|
|
1_suppl |
p. S1-S3
|
artikel
|
| 6 |
Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm
|
Singh, Bramah N.
|
|
2003
|
|
1_suppl |
p. S13-S26
|
artikel
|
| 7 |
Current Medical Management of Chronic Stable Angina
|
Thadani, Udho
|
|
2004
|
|
1_suppl |
p. S11-S29
|
artikel
|
| 8 |
Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials
|
Chaitman, Bernard R.
|
|
2004
|
|
1_suppl |
p. S47-S64
|
artikel
|
| 9 |
Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent
|
Antzelevitch, Charles
|
|
2004
|
|
1_suppl |
p. S65-S83
|
artikel
|
| 10 |
Flight Microangiopathy in Medium-to-Long Distance Flights: Prevention of Edema and Microcirculation Alterations with HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides): A Prospective, Randomized, Controlled Trial
|
Cesarone, M. R.
|
|
2002
|
|
1_suppl |
p. S17-S20
|
artikel
|
| 11 |
HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial
|
Incandela, L.
|
|
2002
|
|
1_suppl |
p. S7-S10
|
artikel
|
| 12 |
Introduction
|
Singh, Bramah N.
|
|
2004
|
|
1_suppl |
p. S1-S2
|
artikel
|
| 13 |
Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy)
|
DeSanctis, M. T.
|
|
2002
|
|
1_suppl |
p. S3-S6
|
artikel
|
| 14 |
Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies
|
Stanley, William C.
|
|
2004
|
|
1_suppl |
p. S31-S45
|
artikel
|
| 15 |
Natural Drugs in Vascular Medicine: New Observations
|
Belcaro, Gianni
|
|
2002
|
|
1_suppl |
p. S1
|
artikel
|
| 16 |
Rhythm or Rate Control in Atrial Fibrillation: Insights from the Randomized Controlled Trials
|
Gronefeld, Gerian
|
|
2003
|
|
1_suppl |
p. S39-S44
|
artikel
|
| 17 |
Tedisamil in Coronary Disease: Additional Benefits in the Therapy of Atrial Fibrillation?
|
Opie, Lionel H.
|
|
2003
|
|
1_suppl |
p. S33-S37
|
artikel
|
| 18 |
Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study
|
Incandela, L.
|
|
2002
|
|
1_suppl |
p. S11-S15
|
artikel
|
| 19 |
Treatment of Edema and Increased Capillary Filtration in Venous Hypertension with HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized, Dose-Ranging Trial
|
Cesarone, M. R.
|
|
2002
|
|
1_suppl |
p. S21-S24
|
artikel
|
| 20 |
Variations in Plasma Free Radicals in Patients with Venous Hypertension with HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized Trial
|
Cesarone, M. R.
|
|
2002
|
|
1_suppl |
p. S25-S28
|
artikel
|
Tijdschrift beschrijving